Diversion Prevention

Controlled substances diversion in health systems can lead to serious patient safety issues, harm to the diverter, and significant liability risk to the organization. Diversion puts patients at risk of harm, directly or indirectly, including inadequate relief of pain, inaccurate documentation of their care in the medical record, exposure to infectious diseases from contaminated needles and drugs, and impaired healthcare worker performance. In addition to patient harm, there are regulatory and legal risks to the organization, including fraudulent billing and liability for resulting damages, and decreased community confidence in the healthcare system.

ASHP Controlled Substances  Diversion Prevention Program Assessment Tool
The ASHP Controlled Substances Diversion Prevention Program (CSDPP) Assessment Tool serves as a practical resource to help organizations determine how their site aligns with the best practice recommendations provided in the ASHP Guidelines on Preventing Diversion of Controlled Substances. Upon completion of the gap assessment, the results identify areas for improvement and allow the user to develop an action plan for their organization.